Valeo Pharma to Present at 2019 Bloom Burton & Co. Healthcare Investor Conference
MONTREAL, April 25, 2019 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH), a Canadian specialty pharmaceutical company dedicated to commercializing innovative prescription products, is pleased to announce that it will be presenting at the Bloom Burton & Co. Healthcare Investor Conference to be held April 30-May 1, 2019 in Toronto, Ontario.
- MONTREAL, April 25, 2019 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH), a Canadian specialty pharmaceutical company dedicated to commercializing innovative prescription products, is pleased to announce that it will be presenting at the Bloom Burton & Co. Healthcare Investor Conference to be held April 30-May 1, 2019 in Toronto, Ontario.
- Valeo's management team will be available for one-on-one investor meetings on both conference days.
- Presentation details are as follows:
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. - About Bloom Burton & Co.
Bloom Burton & Co. (Bloom Burton Securities Inc.) is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies.